The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib.

Source:http://linkedlifedata.com/resource/pubmed/id/17684099

Proc. Natl. Acad. Sci. U.S.A. 2007 Aug 14 104 33 13283-8

Download in:

View as

Triples

General Info

PMID
17684099